The Combination of TRAIL Treatment and Cancer Cell Selective Expression of TRAIL-Death Receptor DR4 Induces Cell Death in TRAIL-Resistant Cancer Cells

다국어 초록 (Multilingual Abstract)

The human telomerase reverse transcriptase (hTERT) promoter can be used for the tumor-specific expression of transgenes in order to induce selective cancer cell death. The hTERTcore promoter is active in cancer cells but not in normal cells. To examine whether the combination of TNF-related apoptosis inducing ligand (TRAIL) treatment and cancer cell-selective expression of the TRAIL-death receptor could induce cell death in TRAIL-resistant cancer cells, we generated a death receptor-4 (DR4)-expressing adenovirus (Ad-hTERT-DR4), in which the expression of DR4 is driven by the hTERT promoter. Upon infection, DR4 expression was slightly increased in cancer cell lines, and cell death was observed in TRAIL-resistant cancer cell lines but not in normal human cells when DR4 infection was combined with TRAIL treatment. We also generated an adenovirus that expresses a secretable isoleucine zipper (ILZ)-fused, extracellular portion of TRAIL (Ad-ILZ- TRAIL). In cells infected with Ad-ILZ-TRAIL, TRAIL was expressed, secreted, oligomerized and biologically active in the induction of apoptosis in TRAIL-sensitive cancer cells. When Ad-hTERT-DR4 infectedTRAIL-resistant HCE4 cells and Ad-ILZ-TRAIL infected TRAIL-resistant HCE7 cells were co-cultured, cell deaths were evident 24 h after co-culture. Taken together, our results reveal that the combination of TRAIL and cancer cell-specific expression of DR4 has the potential to overcome the resistance of cancer cells to TRAIL without inducing significant cell death in normal cells.

참고문헌 (Reference)

1 "hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity" 9 : 30-37, 2002

2 "a potential mediator of p53 tumor suppression" toki (toki): 817-25,

3 "Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo" 157-63, natmed1999

4 "The telomerase reverse transcriptase: components and regulation" 12 : 1073-1085, 1998

5 "The receptor for the cytotoxic ligand TRAIL" 276 : 111-113, 1997

6 "The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand" 60 : 6259-6265, 2000

7 "The TRAIL to selective tumor death" 5 : 146-147, 1999

8 "Telomeres, telomerase and cancer" 274 : 92-97, 1996

9 "Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis" 30 : 35-40, 1998

10 "Telomerase activation by the E6 gene product of human papillomavirus type 16" 380 : 79-82, 1996

11 "Targeting Bcl-xL in esophageal squamous cancer to sensitize to chemotherapy plus TRAIL-induced apoptosis while normal epithelial cells are protected by blockade of caspase 9" 11 : 583-587, 2004

12 "Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes" 62 : 3620-3625, 2002

13 "Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter" 10 : 3535-3541, 2004

14 "Safety and antitumor activity of recombinant soluble Apo2 ligand" 104 : 155-162, 1999

15 "Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma" 59 : 2747-2753, 1999

16 "Molecular determinants of response to TRAIL in killing of normal and cancer cells" 6 : 335-346, 2000

17 "Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells" 21 : 8020-8028, 2002

18 "KILLER/DR5 is a DNA damage- inducible p53-regulated death receptor gene" 17 : 141-143, 1997

19 "Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor- related apoptosis-inducing ligand in vitro and in vivo" 60 : 847-853, 2000

20 "Expression profile of the putative catalytic subunit of the telomerase gene" 58 : 622-625, 1998

21 "Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer" 58 : 1558-1561, 1998

22 "Enhanced TRAIL sensitivity by p53 overexpression in human cancer but not normal cell lines" 18 : 241-247, 2001

23 "Death induction by recombinant native TRAIL and its prevention by a caspase 9 inhibitor in primary human esophageal epithelial cells" 279 : 40044-40052, 2004

24 "Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy" 97 : 1754-1759, 2000

25 "Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft" 9 : 1379-1386, 2002

26 "Cloning of human telomerase catalytic subunit (hTERT)gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells" 59 : 551-557, 1999

27 "Cloning and characterization of human and mouse telomerase RNA gene promoter sequences" 16 : 1345-1350, 1998

28 "Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene" 61 : 3330-3338, 2001

29 "A switch between two- and four-stranded coiled coils in GCN4 leucine zipper mutants" 1401-7, science1993

30 "A simplified system for generating recombinant adenoviruses" 95 : 2509-2514, 1998